VIM- and IMP-type metallo-beta-lactamase-producing Pseudomonas spp. and Acinetobacter spp. in Korean hospitals

• Published in: Emerging infectious diseases Vol. 9; no. 7; pp. 868 - 871
• Main Authors: Lee, Kyungwon, Lee, Wee Gyo, Uh, Young, Ha, Gyoung Yim, Cho, Jihyun, Chong, Yunsop
• Format: Journal Article
• Language: English
• Published: United States U.S. National Center for Infectious Diseases 01.07.2003; Centers for Disease Control and Prevention
• Subjects: Acinetobacter; Acinetobacter - classification; Acinetobacter - drug effects; Acinetobacter - enzymology; Acinetobacter Infections - microbiology; Acinetobacter spp; Alleles; Anti-Bacterial Agents - pharmacology; beta-Lactamases - metabolism; Dispatch; Drug resistance in microorganisms; Drug Resistance, Multiple, Bacterial - genetics; Hospitals; Humans; IMP β-lactamase; Korea; metallo-β-lactamase; Pseudomonas; Pseudomonas - classification; Pseudomonas - drug effects; Pseudomonas - enzymology; Pseudomonas Infections - microbiology; Pseudomonas spp; Statistics; VIM β-lactamase; Korea; Korea, Rep
• ISSN: 1080-6040; 1080-6059
• DOI: 10.3201/eid0907.030012

We determined the occurrence of acquired metallo-b-lactamase (MBL)-producing bacteria in Korean hospitals. Among the isolates nonsusceptible to imipenem that were collected from 28 hospitals from 2000 to 2001, 44 (11.4%) of 387 Pseudomonas spp. and 38 (14.2%) of 267 Acinetobacter spp. produced MBL and had alleles of blaVIM-2 or blaIMP-1. MBL-producing isolates were detected in 60.7% of the hospitals.